ChangThrombosisJournal(2018)16:20Page14of14
90.McKayDG.Progressindisseminatedintravascularcoagulation.CalifMed.120.MammenEF.Coagulationabnormalitiesinliverdisease.HematolOncolClin
1969;111:186–198contd.NorthAm.1992;6:1247–57.
91.McKayDG.ProgressindisseminatedintravascularcoagulationpartII.Calif121.UemuraM,FujimuraY,KoS,MatsumotoM,NakajimaY,FukuiH.
Med.1969;111:279–90.DeterminationofADAMTS13andItsClinicalSignificanceforADAMTS13
92.SueishiK,TakeuchiM.Pathologyofdisseminatedintravascularcoagulation.SupplementationTherapytoImprovetheSurvivalofPatientswith
NihonRinsho.1993;51:30–6.DecompensatedLiverCirrhosis.IntJHepatol.2011;2011:759047.
122.vanDongenPW,EskesTK,GimbrèreJS,SnelP.Maternalmortalitydueto
93.GandoS,LeviM,TohCH.Disseminatedintravascularcoagulation.NatRev
thehepatorenalsyndromeofpre-eclampsia.Acasereport.EurJObstet
DisPrimers.2016;2:16037.
GynecolReprodBiol.1979;9:299–306.
94.BoralBM,WilliamsDJ,BoralLI.DisseminatedIntravascularCoagulation.AmJ
123.IslerCM,RinehartBK,TerroneDA,MayWL,MagannEF,MartinJNJr.The
ClinPathol.2016;146:670–80.
importanceofparitytomajormaternalmorbidityintheeclampticmother
95.WuY,LuoL,NiuT,etal.EvaluationofthenewChineseDisseminated
withHELLPsyndrome.HypertensPregnancy.2003;22:287–94.
IntravascularCoagulationScoringSystemincriticallyillpatients:A
124.AgarwalB,WrightG,GattA,RiddellA,VemalaV,MallettS,ChowdaryP,
multicenterprospectivestudy.SciRep.2017;7:9057.
DavenportA,JalanR,BurroughsA.Evaluationofcoagulationabnormalities
96.TohCH,AlhamdiY,AbramsST.CurrentPathologicalandLaboratory
inacuteliverfailure.JHepatol.2012;57:780–6.
ConsiderationsintheDiagnosisofDisseminatedIntravascularCoagulation.
125.SenzoloM,BurraP,CholongitasE,BurroughsAK.Newinsightsintothe
AnnLabMed.2016;36:505–12.
coagulopathyofliverdiseaseandlivertransplantation.WorldJ
97.LeviM,ScullyM.HowItreatdisseminatedintravascularcoagulation.Blood.
Gastroenterol.2006;12:7725–36.
2018;131:845–54.
126.MallaK,MallaT,HanifM.Prognosticindicatorsinhaemolyticuraemic
98.KotiahSD.BesaEC.Acutepromyelocyticleukemiaclinicalpresentation.
syndrome.KathmanduUnivMedJ(KUMJ).2004;2:291–6.
http://emedicine.medscape.com/article/1495306-clinical
127.TsaiMH,PengYS,ChenYC,etal.Adrenalinsufficiencyinpatientswith
99.ChangJC,GrossHM,JangNS.Disseminatedintravascularcoagulationdue
cirrhosis,severesepsisandsepticshock.Hepatology.2006;43:673–81128.
tointravenousadministrationofhetastarch.AmJMedSci.1990;300:301–3.
128.FranchiniM,ManzatoF,SalvagnoGL,LippiG.Potentialroleofrecombinant
100.HeB,HuS,QiuG,GuW.Clinicalcharacteristicsofacutepromyelocytic
activatedfactorVIIforthetreatmentofseverebleedingassociatedwith
leukemiamanifestingasearlydeath.MolClinOncol.2013;1:908–10.
disseminatedintravascularcoagulation:asystematicreview.BloodCoagul
101.DaverN,KantarjianH,MarcucciG,etal.Clinicalcharacteristicsand
Fibrinolysis.2007;18:589–93.
outcomesinpatientswithacutepromyelocyticleukaemiaand
129.RománE,MendizábalS,JarqueI,etal.Secondarythrombotic
hyperleucocytosis.BrJHaematol.2015;168:646–53.
microangiopathyandeculizumab:Areasonabletherapeuticoption.
102.KanekoT,WadaH.Diagnosticcriteriaandlaboratorytestsfordisseminated
Nefrologia.2017;37:478–91.
intravascularcoagulation.JClinExpHematop.2011;5:67–76.
130.BrocklebankV,KavanaghD.ComplementC5-inhibitingtherapyforthe
103.SlofstraSH,SpekCA,tenCateH.Disseminatedintravascularcoagulation.
thromboticmicroangiopathies:accumulatingevidence,butnotapanacea.
HematolJ.2003;4:295–302.
ClinKidneyJ.2017;10:600–24.
104.FranchiniM,LippiG,ManzatoF.Recentacquisitionsinthepathophysiology,
131.NangakuM,AlpersCE,PippinJ.CD59protectsglomerularendothelialcells
diagnosisandtreatmentofdisseminatedintravascularcoagulation.Thromb
fromimmune-mediatedthromboticmicroangiopathyinrats.JAmSoc
J.2006;4:4.
Nephrol.1998;9:590–7.
105.ChenVM,HoggPJ.Encryptionanddecryptionoftissuefactor.JThromb
Haemost.2013;11(Suppl1):277–84.
106.VersteegHH,RufW.Thiolpathwaysintheregulationoftissuefactor
prothromboticactivity.CurrOpinHematol.2011;18:343–8.
107.RauchU,BondermanD,BohrmannB,etal.Transferoftissuefactorfrom
leukocytestoplateletsismediatedbyCD15andtissuefactor.Blood.
2000;96:170–5.
108.EsmonCT.Theinteractionsbetweeninflammationandcoagulation.
BrJHaematol.2005;131:417–30.
109.Pet?j?J.Inflammationandcoagulation.Anoverview.ThrombRes.2011;
127(Suppl2):S34–7.
110.DemetzG,OttI.TheInterfacebetweenInflammationandCoagulationin
CardiovascularDisease.IntJInflam.2012;2012:860301.
111.LeviM,vanderPollT.Inflammationandcoagulation.CritCareMed.
2010;38(2Suppl):S26–34.
112.TaylorFBJr,WadaH,KinasewitzG.Descriptionofcompensatedand
uncompensateddisseminatedintravascularcoagulation(DIC)responses
(non-overtandovertDIC)inbaboonmodelsofintravenousand
intraperitonealEscherichiacolisepsisandinthehumanmodelof
endotoxemia:towardabetterdefinitionofDIC.CritCareMed.
2000;28(9Suppl):S12–9.
113.TaylorFBJr,KinasewitzGT.Thediagnosisandmanagementofdisseminated
intravascularcoagulation.CurrHematolRep.2002;1:34–40.
114.FourrierF.Severesepsis,coagulation,andfibrinolysis:deadendorone
way?CritCareMed.2012;40:2704–8.
115.MarshallJC.Whyhaveclinicaltrialsinsepsisfailed?TrendsMolMed.2014;
20:195–203.
116.KularatneSA,ImbulpitiyaIV,AbeysekeraRA,WadugeRN,RajapakseRP,
WeerakoonKG.Extensivehaemorrhagicnecrosisofliverisanunpredictable
fatalcomplicationindengueinfection:apostmortemstudy.BMCInfectDis.
2014;14:141.
117.TalwaniR,GilliamBL,HowellC.Infectiousdiseasesandtheliver.ClinLiver
Dis.2011;15:111–30.
118.SamantaJ,SharmaV.Dengueanditseffectsonliver.WorldJClinCases.
2015;3:125–31.
119.ElSayedSM,AbdelrahmanAA,OzbakHA,etal.Updatesindiagnosisand
managementofEbolahemorrhagicfever.JResMedSci.2016;21:84. |
|
